Fusion Antibodies plc (AIM:FAB)
London flag London · Delayed Price · Currency is GBP · Price in GBX
6.37
+0.07 (1.06%)
Jul 8, 2025, 2:38 PM GMT+1

Fusion Antibodies Market Cap

Fusion Antibodies has a market cap or net worth of 7.16 million as of July 8, 2025. Its market cap has increased by 134.63% in one year.

Market Cap
7.16M
Enterprise Value
6.75M
Revenue
1.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.37

Market Cap Chart

Since December 18, 2017, Fusion Antibodies's market cap has decreased from 27.28M to 7.16M, a decrease of -73.75%. That is a compound annual growth rate of -16.22%.

History

DateMarket Cap% Change
Jul 7, 20257.16M5.85%
Dec 31, 20246.76M167.72%
Dec 29, 20232.53M-78.42%
Dec 30, 202211.71M-59.09%
Dec 31, 202128.62M-9.27%
Dec 31, 202031.54M81.89%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
AstraZeneca 160.28B
GSK plc 56.85B
Haleon 33.95B
Smith & Nephew 9.73B
ConvaTec Group 5.40B
Hikma Pharmaceuticals 4.36B
HUTCHMED (China) 1.96B
Oxford Nanopore Technologies 1.42B
Market Cap Rankings